HealthcareMachine Learning4 min reading time

CellCarta, Imagene AI Broaden Ties on AI Biomarkers, Companion Diagnostics

Unite.AI
Read the full article
CellCarta and Imagene AI have expanded their partnership to jointly develop and scale AI-driven biomarker and companion diagnostic programs for biopharma, currently collaborating on projects with two global pharmaceutical firms. Their work integrates Imagene AI's assay development and biomarker prediction with CellCarta's diagnostic and regulatory expertise, including applications in immunohistochemistry and lung cancer biomarker prediction.

More in Healthcare

Healthcare2 min read

Google launches $180 Fitbit Edge with a bigger screen and AI coach

The Next Web
Healthcare5 min read

As US medical debt grows, AI will be used more to collect it

The Guardian
Healthcare5 min read

Healthcare AI's Pilot-To-Production Problem

Forbes